Optimal Sampling Times in Population Pharmacokinetic Studies
From MaRDI portal
Publication:3441347
DOI10.1111/1467-9876.00239zbMath1112.62310OpenAlexW1990902792MaRDI QIDQ3441347
Peter Mueller, Jonathan R. Stroud, Gary L. Rosner
Publication date: 30 May 2007
Published in: Journal of the Royal Statistical Society Series C: Applied Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/1467-9876.00239
Related Items (16)
Towards Bayesian experimental design for nonlinear models that require a large number of sampling times ⋮ Optimal design in geostatistics under preferential sampling ⋮ Optimal sampling for repeated binary measurements ⋮ A pseudo-marginal sequential Monte Carlo algorithm for random effects models in Bayesian sequential design ⋮ Developments of the total entropy utility function for the dual purpose of model discrimination and parameter estimation in Bayesian design ⋮ Optimal Bayesian design for discriminating between models with intractable likelihoods in epidemiology ⋮ Simulation-based fully Bayesian experimental design for mixed effects models ⋮ A Review of Modern Computational Algorithms for Bayesian Optimal Design ⋮ Sequential D-optimal designs for generalized linear mixed models ⋮ A Laplace-based algorithm for Bayesian adaptive design ⋮ Examples of the use of an equivalence theorem in constructing optimum experimental designs for random-effects nonlinear regression models ⋮ Robust designs for multivariate logistic regression ⋮ Bayesian experimental design for long-term longitudinal HIV dynamic studies ⋮ FPCA-based method to select optimal sampling schedules that capture between-subject variability in longitudinal studies ⋮ Bayesian Experimental Design for Nonlinear Mixed‐Effects Models with Application to HIV Dynamics ⋮ Horwitz’s Rule, Transforming Both Sides and the Design of Experiments for Mechanistic Models
This page was built for publication: Optimal Sampling Times in Population Pharmacokinetic Studies
